PINK1 and Parkinson disease: However, the relative contribution of these pathways to Pink1–related pathology remains unclear [11], [20]–[22] nor is it known whether acutely improving ETC function is a valuable therapeutic approach for PD patients that suffer from Pink1-induced mitochondrial dysfunction.